These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14091588)

  • 21. The copper and iron content of brain and liver in the normal and in hepato-lenticular degeneration.
    CUMINGS JN
    Brain; 1948 Dec; 71(Pt. 4):410-5. PubMed ID: 18124738
    [No Abstract]   [Full Text] [Related]  

  • 22. Wilson's disease patients with normal ceruloplasmin levels.
    Yüce A; Koçak N; Ozen H; Gürakan F
    Turk J Pediatr; 1999; 41(1):99-102. PubMed ID: 10770682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the oxidase properties of ceruloplasmin: factors in normal and Wilson's-disease serum affecting oxidase activity.
    WALSHE JM
    J Clin Invest; 1963 Jul; 42(7):1048-53. PubMed ID: 13998657
    [No Abstract]   [Full Text] [Related]  

  • 24. HEPATOLENTICULAR DEGENERATION; CLINICAL AND BIOCHEMICAL STUDY OF THREE CASES.
    CANELAS HM; ESCALANTE OD; DE JORGE FB; ROCHA-QINTAO EC
    Arq Neuropsiquiatr; 1963 Dec; 21():229-50. PubMed ID: 14119988
    [No Abstract]   [Full Text] [Related]  

  • 25. Further investigations on ceruloplasmin in hepatolenticular degeneration and on the effect of copper on oxidase activity of ceruloplasmin.
    Wald I; Galewicz A; Górska D
    Pol Med J; 1972; 11(3):733-9. PubMed ID: 5047986
    [No Abstract]   [Full Text] [Related]  

  • 26. [Features of the course and disorders of copper and ceruloplasmin metabolism in hepatolenticular degeneration].
    Davidenkova EF; Neĭfakh SA; Butomo IV; Mashkov BA; Lapchenkov VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):982-90. PubMed ID: 5598796
    [No Abstract]   [Full Text] [Related]  

  • 27. [Copper, ceruloplasmin and the pathogenesis of hepatolenticular degeneration].
    Chromý K
    Cas Lek Cesk; 1965 Oct; 104(43):1173-7. PubMed ID: 5322100
    [No Abstract]   [Full Text] [Related]  

  • 28. BIOCHEMICAL ASPECTS OF COPPER AND AROMATIC AMINES IN RELATION TO THE EXTRAPYRAMIDAL SYSTEM.
    WALAAS E; WALAAS O
    Acta Neurol Scand Suppl; 1963; 39(4):SUPPL4:84-94. PubMed ID: 14057524
    [No Abstract]   [Full Text] [Related]  

  • 29. [Copper metabolism in hepato-lenticular degeneration thiol therapy].
    KONOVALOV NV; MUTTEL'SHTEDT AA; BAUMAN LK; GOTOVTSEVA EV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1957; 57(1):39-48. PubMed ID: 13434449
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical features of hepatolenticular degeneration in children].
    Lu Y; Wang XH; Wang JS
    Zhonghua Gan Zang Bing Za Zhi; 2008 Mar; 16(3):224-6. PubMed ID: 18364085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [HEPATOLENTICULAR DEGENERATION, ACUTE ANEMIA AND HEPATIC INSUFFICIENCY LONG PRECEDING THE NEUROLOGICAL SYMPTOMS].
    TURPIN R; CAILLE B; LAFOURCADE J; JEROME H; BOUTELIER D; DEFRANOUX A
    Ann Pediatr (Paris); 1963; 10():277-83. PubMed ID: 14126013
    [No Abstract]   [Full Text] [Related]  

  • 32. Failure of copper incorporation into ceruloplasmin in the Golgi apparatus of LEC rat hepatocytes.
    Murata Y; Yamakawa E; Iizuka T; Kodama H; Abe T; Seki Y; Kodama M
    Biochem Biophys Res Commun; 1995 Apr; 209(1):349-55. PubMed ID: 7726856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical aspects of hepato-lenticular degeneration].
    Fazio C; Agnoli A; Casacchia M
    Epatologia; 1970; 16(1):41-4. PubMed ID: 5525564
    [No Abstract]   [Full Text] [Related]  

  • 34. [Wilson's disease (hepatolenticular degeneration)].
    Bickel H
    Internist (Berl); 1966 Jan; 7(1):27-33 passim. PubMed ID: 4964272
    [No Abstract]   [Full Text] [Related]  

  • 35. [Electrophoretic pattern of blood proteins and copper level and clinical symptoms during BAL therapy in hepato-lenticular degeneration].
    WENDER M; WYSOCKI K; MAGAS S
    Neurol Neurochir Psychiatr Pol; 1955; 5(6):593-603. PubMed ID: 13309594
    [No Abstract]   [Full Text] [Related]  

  • 36. DISTURBANCES OF COPPER AND AMINO ACID METABOLISM IN CLINICALLY HEALTHY RELATIVES OF PATIENTS WITH HEPATOLENTICULAR DEGENERATION.
    PATRUNOVA VP
    Fed Proc Transl Suppl; 1964; 23():340-2. PubMed ID: 14145670
    [No Abstract]   [Full Text] [Related]  

  • 37. On keeping one's eye on the ball: analysis of biologic specimens for copper.
    Scheinberg IH
    N Engl J Med; 1969 May; 280(22):1239-40. PubMed ID: 5787932
    [No Abstract]   [Full Text] [Related]  

  • 38. [Test of stimulation of ceruloplasmin activity and copper concentration as affected by diphenylhydantoin (phenytoin, TSC) in the diagnosis of hepatolenticular degeneration].
    Pakszys W; Ligezińska B; Szymański H
    Pol Tyg Lek; 1982 Nov; 37(45):1353-7. PubMed ID: 7163091
    [No Abstract]   [Full Text] [Related]  

  • 39. The metabolic disorder in hepato-lenticular degeneration.
    MATTHEWS WB; MILNE MD; BELL M
    Q J Med; 1952 Oct; 21(84):425-46. PubMed ID: 13004260
    [No Abstract]   [Full Text] [Related]  

  • 40. CLINICAL AND PATHOLOGICAL CHARACTERISTICS IN WILSON'S DISEASE IN CASES UNDER TEN YEARS OF AGE.
    ARIMA M; KOMIYA K; KAMOSHITA S; MUKAI N
    Paediatr Univ Tokyo; 1963 Dec; 9():17-22. PubMed ID: 14157269
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.